Abstract
The aim of this study was to evaluate the histopathological impact, effectiveness, and safety of two hemostatic agents, Ankaferd Blood Stopper (ABS) and microporous polysaccharide hemospheres (MPH), in an experimental rabbit epistaxis model. Rabbits were randomly assigned, using a computerized random number generator, to the following three groups of six animals: group 1 (control, irrigated with saline); group 2 (ABS-treated); and group 3 (MPH-treated). In all groups, a standardized rabbit epistaxis model was used. Hemostasis time and extent of nasal bleeding were measured to compare the hemostatic effect of ABS and MPH among groups. Septums were removed for histopathological analysis, 7 days after the procedure. ABS reduced hemostasis time to 104.2 s and amount of bleeding to 20.5 mg. MPH reduced hemostasis time to 71.7 s and amount of bleeding to 11.5 mg. Mean bleeding time in wounds administered ABS and MPH was significantly shorter compared with wounds administered isotonic saline solution (p = 0.004). ABS and MPH application decreased bleeding significantly compared with the control group (p = 0.004). Bleeding time and amount in the MPH group was significantly reduced compared with the ABS group (p = 0.013 and p = 0.004, respectively). There was no significant difference in the histopathological evaluation results between the ABS, MPH, and control groups. Our data indicate that both ABS and MPH represent safe, effective, and fast-acting hemostatic agents in the management of epistaxis. MPH was more effective than ABS in terms of hemostasis time and amount of bleeding.
Similar content being viewed by others
References
Duncan IC, Fourie PA, le Grange CE, van der Walt HA (2004) Endovascular treatment of intractable epistaxis—results of a 4-year local audit. S Afr Med J 94(5):373–378
Meric Teker A, Korkut AY, Kahya V, Gedikli O (2010) Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 267(9):1377–1381
Gifford TO, Orlandi RR (2008) Epistaxis. Otolaryngol Clin North Am 41(3):525–536
Kurtaran H, Ark N, Serife Ugur K, Sert H, Ozboduroglu AA, Kosar A, Gunduz M (2010) Effects of a topical hemostatic agent on an epistaxis model in rabbits. Curr Ther Res Clin Exp 71(2):105–110
Kucik CJ, Clenney T (2005) Management of epistaxis. Am Fam Physician 71(2):305–311
Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Ercetin S, Kirazli S, Firat HC (2009) The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis 20(3):185–190
Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC (2008) Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 36(1):163–170
Bilgili H, Kosar A, Kurt M, Onal IK, Goker H, Captug O, Shorbagi A, Turgut M, Kekilli M, Kurt OK, Kirazli S, Aksu S, Haznedaroglu IC (2009) Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract 18(3):165–169
Emmez H, Tonge M, Tokgoz N, Durdag E, Gonul I, Ceviker N (2010) Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: a study of efficacy and safety. Turk Neurosurg 20(4):485–491
Willems PW, Farb RI, Agid R (2009) Endovascular treatment of epistaxis. AJNR 30(9):1637–1645
Sudmann B, Bang G, Sudmann E (2006) Histologically verified bone wax (beeswax) granuloma after median sternotomy in 17 of 18 autopsy cases. Pathology 38(2):138–141
Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(Suppl A):19–24
Bosscha K, Nieuwenhuijs VB, Gooszen AW, van Duijvenbode-Beumer H, Visser MR, Verweij WR, Akkermans LM (2000) A standardised and reproducible model of intraabdominal infection and abscess formation in rats. Eur J Surg 166(12):963–967
Bhatnagar RK, Berry S (2004) Selective surgicel packing for the treatment of posterior epistaxis. Ear Nose Throat J 83(9):633–634
Mathiasen RA, Cruz RM (2005) Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 115(5):899–902
Aydin S (2009) Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 37(1):279
Shorbagi A, Sivri B (2010) Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper: a novel indication (with video). Gastrointest Endosc 72(3):666–667
Singer AJ, McClain SA, Katz A (2004) A porcine epistaxis model: hemostatic effects of octylcyanoacrylate. Otolaryngol Head Neck Surg 130(5):553–557
Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC (2008) Endoscopic application of Ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol 103(8):2156–2158
Cipil HS, Kosar A, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Koroglu M, Kirazli S, Firat HC (2009) In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost 15(3):270–276
Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr (2008) Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery 63(4):369–372
Iynen I, Sogut O, Kose R (2011) The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model. Otolaryngol Head Neck Surg 145(5):840–844
Humphreys MR, Lingeman JE, Terry C, Castle EP, Andrews PE, Gettman MT, Ereth MH (2008) Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model. J Endourol 22(6):1375–1381
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations to the subject matter or materials included.
Rights and permissions
About this article
Cite this article
Yurttas, V., Sereflican, M., Terzi, E.H. et al. Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model. Eur Arch Otorhinolaryngol 273, 933–938 (2016). https://doi.org/10.1007/s00405-015-3692-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3692-8